AI assistant
Sending…
TuHURA Biosciences, Inc./NV — Director's Dealing 2021
Jan 4, 2021
34026_dirs_2021-01-04_bb9d59af-858b-4413-96df-f69bf79e93f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Kintara Therapeutics, Inc. (KTRA)
CIK: 0001498382
Period of Report: 2020-12-31
Reporting Person: Brown Dennis M (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Common Stock | J | 17 | $0.00 | Acquired | 6045 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 53750 | Indirect |
Footnotes
F1: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
F2: Held by Valent Technologies LLC, of which the reporting person is the sole member and owner and holds sole voting and dispositive power over its shares.
More from TuHURA Biosciences, Inc./NV
Capital/Financing Update
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Capital/Financing Update
2026
Apr 22
Capital/Financing Update
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Apr 1
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17